The latest closing stock price for Arbutus Biopharma as of September 19, 2024 is 4.14.
An investor who bought $1,000 worth of Arbutus Biopharma stock at the IPO in 2015 would have $-606 today, roughly -1 times their original investment - a -9.82% compound annual growth rate over 9 years.
The all-time high Arbutus Biopharma stock closing price was 12.35 on August 02, 2018.
The Arbutus Biopharma 52-week high stock price is 4.72, which is 14% above the current share price.
The Arbutus Biopharma 52-week low stock price is 1.69, which is 59.2% below the current share price.
The average Arbutus Biopharma stock price for the last 52 weeks is 2.80.
An investor who bought $1,000 worth of Arbutus Biopharma stock at the IPO in 2015 would have $-606 today, roughly -1 times their original investment - a -9.82% compound annual growth rate over 9 years.
The all-time high Arbutus Biopharma stock closing price was 12.35 on August 02, 2018.
The Arbutus Biopharma 52-week high stock price is 4.72, which is 14% above the current share price.
The Arbutus Biopharma 52-week low stock price is 1.69, which is 59.2% below the current share price.
The average Arbutus Biopharma stock price for the last 52 weeks is 2.80.